Compare
Candriam Eq. L Biotechnology N EUR Hdg LU2346866077
Currency allocation
| United States Dollar | 91.08% |
| Euro | 4.53% |
| Danish Krone | 3.00% |
| Non definito | 0.97% |
| Swiss Franc | 0.38% |
| British Pound | 0.05% |
Update date: 1/30/2026
Geographical allocation
| North America | 82.37% |
| Europe | 16.66% |
| World / Multiple areas | 0.97% |
Update date: 1/30/2026
Sector allocation
| Health Care | 95.24% |
| MATERIALS & COMMODITIES | 1.73% |
| INDUSTRIALS | 1.19% |
| Not Available | 0.97% |
| FINANCIALS | 0.50% |
| Consumer Staples | 0.38% |
Update date: 1/30/2026
Top Ten holdings
| GILEAD SCIENCES INC | 5.20% |
| VERTEX PHARMACEUTICALS INC | 5.10% |
| AMGEN INC | 4.23% |
| ALNYLAM PHARMACEUTICALS INC | 3.59% |
| REGENERON PHARMACEUTICALS | 3.52% |
| BIOGEN INC | 3.19% |
| INSMED INC | 2.98% |
| ROIVANT SCIENCES LTD | 2.51% |
| IONIS PHARMACEUTICALS INC | 2.50% |
| MIRUM PHARMACEUTICALS INC | 2.35% |
Update date: 1/30/2026